BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zheng Z, Wang H, Li L, Zhang S, Zhang C, Zhang H, Ji F, Liu X, Zhu K, Kong G, Li Z. Splenectomy enhances the Ly6Clow phenotype in hepatic macrophages by activating the ERK1/2 pathway during liver fibrosis. Int Immunopharmacol 2020;86:106762. [PMID: 32652503 DOI: 10.1016/j.intimp.2020.106762] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Murotomi K, Tawara H, Sutoh M, Yasunaga M. Iron-accumulating splenocytes may exacerbate non-alcoholic steatohepatitis through the production of proinflammatory cytokines and reactive oxygen species. Exp Biol Med (Maywood) 2022;:15353702221077218. [PMID: 35187967 DOI: 10.1177/15353702221077218] [Reference Citation Analysis]
2 Mo C, Xie S, Liu B, Zhong W, Zeng T, Huang S, Lai Y, Deng G, Zhou C, Yan W, Chen Y, Huang S, Gao L, Lv Z. Indoleamine 2,3-dioxygenase 1 limits hepatic inflammatory cells recruitment and promotes bile duct ligation-induced liver fibrosis. Cell Death Dis 2021;12:16. [PMID: 33414436 DOI: 10.1038/s41419-020-03277-0] [Reference Citation Analysis]
3 Cheng D, Chai J, Wang H, Fu L, Peng S, Ni X. Hepatic macrophages: Key players in the development and progression of liver fibrosis. Liver Int 2021. [PMID: 33966318 DOI: 10.1111/liv.14940] [Reference Citation Analysis]